Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Irritable Bowel Syndrome

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    January 2025
  1. AKHLAQ S, Kazmi N, Kazmi SMH, Atiq M, et al
    Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0312506.
    PubMed     Abstract available


  2. TATTAN M, Rosmalen J, Hanssen D
    Factors associated with receiving a Functional Disorder diagnostic label: A systematic review.
    PLoS One. 2025;20:e0317236.
    PubMed     Abstract available


  3. ZHOU J, Lamichhane N, Xu Z, Wang J, et al
    The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314678.
    PubMed     Abstract available


  4. EKMAN L, Tufvesson H, Englund E, Dahlin LB, et al
    Symptoms and objective signs of peripheral sensory neuropathy in POTS and correlations to gastrointestinal symptoms.
    PLoS One. 2025;20:e0327549.
    PubMed     Abstract available



  5. Editorial Note: Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0331058.
    PubMed    


    January 2024
  6. LEE KS, Song IS, Kim ES, Kim J, et al
    Machine learning analysis with population data for the associations of preterm birth with temporomandibular disorder and gastrointestinal diseases.
    PLoS One. 2024;19:e0296329.
    PubMed     Abstract available


  7. JORGENSEN T, Jacobsen RK, Saebye D, Petersen MW, et al
    Lipid metabolism and functional somatic disorders in the general population. The DanFunD study.
    PLoS One. 2024;19:e0296799.
    PubMed     Abstract available


  8. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
    Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
    PLoS One. 2024;19:e0297836.
    PubMed     Abstract available


  9. SUN G, Jiang Y
    Major depressive disorder and irritable bowel syndrome risk: A Mendelian randomization study.
    PLoS One. 2024;19:e0300251.
    PubMed     Abstract available


  10. DAI X, Liang M, Dai Y, Ding S, et al
    Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
    PLoS One. 2024;19:e0298963.
    PubMed     Abstract available


  11. GUO Y, Lu Q, Yang XJ, He Y, et al
    Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
    PLoS One. 2024;19:e0299376.
    PubMed     Abstract available


  12. SCHOVSBO SU, Karhus LL, Bjerregaard AA, Petersen MW, et al
    Fluctuation of functional somatic disorders in a population-based cohort. The DanFunD study.
    PLoS One. 2024;19:e0312031.
    PubMed     Abstract available


  13. KONIG J, Roca Rubio MF, Forsgard RA, Rode J, et al
    The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.
    PLoS One. 2024;19:e0312464.
    PubMed     Abstract available


    January 2023
  14. KHEMNU N, Serichantalergs O, Ruekit S, Lertsethtakarn P, et al
    Description of novel capsule biosynthesis loci of Campylobacter jejuni clinical isolates from South and South-East Asia.
    PLoS One. 2023;18:e0280583.
    PubMed     Abstract available


  15. SCHALLER A, Vanderzande S, Peace C
    Deducing genotypes for loci of interest from SNP array data via haplotype sharing, demonstrated for apple and cherry.
    PLoS One. 2023;18:e0272888.
    PubMed     Abstract available


  16. RAO STRB, Turek I, Irving HR
    Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa.
    PLoS One. 2023;18:e0281507.
    PubMed     Abstract available


  17. SCHORLING E, Lick S, Steinberg P, Bruggemann DA, et al
    Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis.
    PLoS One. 2023;18:e0283865.
    PubMed     Abstract available


  18. CREED F
    Psychiatric disorders comorbid with general medical illnesses and functional somatic disorders: The Lifelines cohort study.
    PLoS One. 2023;18:e0286410.
    PubMed     Abstract available


  19. WANG Y, Ke W, Gan J, Zhu H, et al
    MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-kappaB-MLCK signaling pathway.
    PLoS One. 2023;18:e0287597.
    PubMed     Abstract available


  20. TRAN TTT, Luu MN, Tran LL, Nguyen D, et al
    Association of mental health conditions and functional gastrointestinal disorders among Vietnamese new-entry medical students.
    PLoS One. 2023;18:e0289123.
    PubMed     Abstract available


  21. MADRIGAL-VALENCIA TL, Saavedra-Montanez M, Perez-Torres A, Hernandez J, et al
    First identification and characterization of ovine gammaherpesvirus type 2 in horses and artiodactyla from an outbreak of malignant catarrhal fever in Mexico.
    PLoS One. 2023;18:e0290309.
    PubMed     Abstract available


  22. GU Y, You Y, Guo G, Xie F, et al
    Effect of Prolong-life-with-nine-turn-method (Yan Nian Jiu Zhuan) Qigong on fatigue and gastrointestinal function in patients with chronic fatigue syndrome: Study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0287287.
    PubMed     Abstract available


  23. TIAN J, Li T, Zhao J, Li D, et al
    Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    PLoS One. 2023;18:e0295077.
    PubMed     Abstract available


    January 2022
  24. PAGAN-BUSIGO JE, Lopez-Carrasquillo J, Appleyard CB, Torres-Reveron A, et al
    Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
    PLoS One. 2022;17:e0264909.
    PubMed     Abstract available


  25. IVASHKIN VT, Kudryavtseva AV, Krasnov GS, Poluektov YM, et al
    Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
    PLoS One. 2022;17:e0263880.
    PubMed     Abstract available


  26. OZAKA S, Sonoda A, Ariki S, Minata M, et al
    Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PLoS One. 2022;17:e0269698.
    PubMed     Abstract available


  27. ABID S, Rehman H, Awan S, Artani A, et al
    Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.
    PLoS One. 2022;17:e0268403.
    PubMed     Abstract available


  28. LIU J, Peng R, Tan Q, Li B, et al
    Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea.
    PLoS One. 2022;17:e0273853.
    PubMed     Abstract available


  29. GROZIC A, Coker K, Dussik CM, Sabir MS, et al
    Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.
    PLoS One. 2022;17:e0275683.
    PubMed     Abstract available


  30. HINSE M, Thronicke A, Berghofer A, Matthes H, et al
    New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up.
    PLoS One. 2022;17:e0277880.
    PubMed     Abstract available


  31. NAKATA R, Tanaka F, Sugawara N, Kojima Y, et al
    Analysis of autonomic function during natural defecation in patients with irritable bowel syndrome using real-time recording with a wearable device.
    PLoS One. 2022;17:e0278922.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.